These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9310807)

  • 61. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiac and circulatory response to the intravenous administration of urapidil during general anaesthesia.
    Fontana F; Allaria B; Brunetti B; Arienta R; Favaro M; Trivellato A; Rusconi MG
    Drugs Exp Clin Res; 1990; 16(6):315-8. PubMed ID: 2086167
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Guidelines for the drug treatment of hypertensive crises.
    Hirschl MM
    Drugs; 1995 Dec; 50(6):991-1000. PubMed ID: 8612477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Analysis of the baroreflex activation of the sympathetic system in waking cats induced by urapidil and sodium nitroprusside].
    Medvedev OS; Kuz'min AI; Iashina LP; Rozin BD; Maĭorov DN
    Farmakol Toksikol; 1988; 51(4):53-6. PubMed ID: 3191973
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
    Wacker JR; Wagner BK; Briese V; Schauf B; Heilmann L; Bartz C; Hopp H
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):160-5. PubMed ID: 16253414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of urapidil in the management of essential hypertension. A comparison with captopril.
    Rosenthal J; Haerlin R; Schäfer N; Christ B; Wurst W
    Drugs; 1988; 35 Suppl 6():147-55. PubMed ID: 3042354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved orthostatic dysregulation record after administration of a sustained-release form of urapidil.
    Kirsten R; Nelson K; Kirch W; Hutt HJ; Molz KH; Theodor R; Nieder M; Dilger C; Haerlin R; Wurst W
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):338-41. PubMed ID: 2777422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular and metabolic profile during intervention with urapidil in humans.
    Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
    Hypertension; 1985; 7(6 Pt 1):963-71. PubMed ID: 3908316
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.
    Taniguchi K; Nakamura S; Iesaka Y; Nitta M; Ito H; Kirigaya H; Takeuchi J; Fujiwara H; Iizumi T; Inada M
    Clin Ther; 1985; 7(5):559-67. PubMed ID: 4053145
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypertensive crisis during pregnancy and postpartum period.
    Too GT; Hill JB
    Semin Perinatol; 2013 Aug; 37(4):280-7. PubMed ID: 23916027
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of urapidil on intracranial pressure and intracranial compliance in dogs.
    Puchstein C; Van Aken H; Anger C; Hidding J
    Br J Anaesth; 1983 May; 55(5):443-8. PubMed ID: 6849727
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of urapidil, ketanserin and sodium nitroprusside on venous admixture and arterial oxygenation following coronary artery bypass grafting.
    Möllhoff T; Van Aken H; Mulier JP; Müller E; Lauwers P
    Br J Anaesth; 1990 Apr; 64(4):493-7. PubMed ID: 2334625
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Role of urapidil in the treatment of acute hypertension].
    Lehot JJ; Bonnefoy E; Dalmas JP; Filley S; Bastien O; George M
    Cah Anesthesiol; 1995; 43(1):67-76. PubMed ID: 7671060
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A new preparation of nifedipine for sublingual application in hypertensive urgencies.
    Kürkciyan I; Sterz F; Roden M; Heinz G; Hirschl MM; Müllner M; Laggner AN
    Angiology; 1994 Jul; 45(7):629-35. PubMed ID: 8024162
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension.
    Haenni A; Lithell H
    Metabolism; 1996 Oct; 45(10):1221-9. PubMed ID: 8843176
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics and pharmacodynamics of urapidil in severe hypertension.
    Bottorff MB; Hoon TJ; Rodman JH; Gerlach PA; Ramanathan KB
    J Clin Pharmacol; 1988 May; 28(5):420-6. PubMed ID: 3392239
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
    Gretler DD; Elliott WJ; Moscucci M; Childers RW; Murphy MB
    Arch Intern Med; 1992 Dec; 152(12):2445-8. PubMed ID: 1360793
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of Clinical Efficacy of Sodium Nitroprusside and Urapidil in the Treatment of Acute Hypertensive Cerebral Hemorrhage.
    Yang R; Wang Z; Jia Y; Li H; Mou Y
    J Healthc Eng; 2022; 2022():2209070. PubMed ID: 35388331
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Review of studies with urapidil in elderly hypertensives.
    Hansson L; Petitet A
    Blood Press Suppl; 1995; 3():21-5. PubMed ID: 8535538
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of urapidil on cerebrospinal fluid pressure in humans with uncompromised intracranial compliance.
    Hörmann C; Luz G; Langmayr J; Schalow S; Benzer A
    Intensive Care Med; 1995 Oct; 21(10):853-5. PubMed ID: 8557877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.